Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166061 | SCV000216823 | likely benign | Hereditary cancer-predisposing syndrome | 2014-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000679264 | SCV000528571 | likely benign | not provided | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166061 | SCV000689789 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080089 | SCV000751264 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679264 | SCV000805942 | likely benign | not provided | 2018-01-12 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000679264 | SCV000888171 | likely benign | not provided | 2018-01-07 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000444532 | SCV001360802 | likely benign | not specified | 2020-01-31 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995475 | SCV004835239 | likely benign | Lynch syndrome | 2023-04-03 | criteria provided, single submitter | clinical testing | |
True Health Diagnostics | RCV000166061 | SCV000788016 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-10 | no assertion criteria provided | clinical testing |